• Skip to main content
  • Skip to secondary menu
  • Skip to primary sidebar
  • Skip to secondary sidebar
  • Skip to footer

  • Opinion
  • Health IT
    • Behavioral Health
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Patient Engagement
    • Population Health Management
    • Revenue Cycle Management
    • Social Determinants of Health
  • Digital Health
    • AI
    • Blockchain
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • M&A
  • Value-based Care
    • Accountable Care (ACOs)
    • Medicare Advantage
  • Life Sciences
  • Research

Apple ResearchKit Now Available To All Medical Researchers

by Fred Pennic 04/14/2015 Leave a Comment

  • LinkedIn
  • Twitter
  • Facebook
  • Email
  • Print

11k Sign Up for Apple's ResearchKit In Less Than 24 Hours

Apple has announced that ResearchKit, an open source software framework designed for medical and health research that helps doctors, scientists and other researchers gather data more frequently and more accurately from participants using mobile devices, is now available to researchers and developers.

The platform was first launched last month with five inaugural research apps developed using ResearchKit study asthma, breast cancer, cardiovascular disease, diabetes and Parkinson’s disease, and have enrolled over 60,000 iPhone® users in just the first few weeks of being available on the App Store.

Starting today, medical researchers all over the world will now be able to use ResearchKit to develop their own apps and developers can also contribute new research modules to the open source framework. When granted permission by the participant, ResearchKit apps can access data from advanced iPhone sensors like the accelerometer, gyroscope, microphone and GPS to gain insight into a participant’s activity levels, motor impairments, memory and more. ResearchKit works seamlessly with HealthKit™, a software framework Apple introduced with iOS 8 to provide developers the ability for health and fitness apps to communicate with each other.

ResearchKit also eliminates handwritten surveys and lengthy forms — and the expensive data entry and storage that come with them for medical researchers. By allowing participants to complete tasks or submit surveys right from iPhone, ResearchKit’s initial customizable modules address the most common elements found in research studies—participant consent, surveys and active tasks. 

– Participant consent: Participant consent is a critical element to research studies, and with ResearchKit researchers can access a visual e-consent template that can be customized to explain the details of the study and obtain participant signatures. This module makes it easy for the researcher to include elements such as video segments explaining the study and an interactive quiz to confirm the participant’s understanding.

– Surveys: The survey module provides a pre-built user interface that makes it easy to customize questions and answers for study participants to complete and immediately share with researchers. 

– Active Tasks: The Active Task module enables researchers to gather more targeted data for their study by inviting participants to perform activities that generate data using iPhone’s advanced sensors. Initial Active Task modules include tasks to measure motor activities, fitness, cognition and voice, and with the framework available as open source, the research community can contribute even more active tasks to ResearchKit.

SOURCE: Apple

  • LinkedIn
  • Twitter
  • Facebook
  • Email
  • Print

Tagged With: Apple ResearchKit, HIMSS 2015

Tap Native

Get in-depth healthcare technology analysis and commentary delivered straight to your email weekly

Reader Interactions

Primary Sidebar

Subscribe to HIT Consultant

Latest insightful articles delivered straight to your inbox weekly.

Submit a Tip or Pitch

Featured Insights

2025 EMR Software Pricing Guide

2025 EMR Software Pricing Guide

Featured Interview

Paradigm Shift in Diabetes Care with Studio Clinics: Q&A with Reach7 Founder Chun Yong

Most-Read

Medtronic to Separate Diabetes Business into New Standalone Company

Medtronic to Separate Diabetes Business into New Standalone Company

White House, IBM Partner to Fight COVID-19 Using Supercomputers

HHS Sets Pricing Targets for Trump’s EO on Most-Favored-Nation Drug Pricing

23andMe to Mine Genetic Data for Drug Discovery

Regeneron to Acquire Key 23andMe Assets for $256M, Pledges Continuity of Consumer Genome Services

CureIS Healthcare Sues Epic: Alleges Anti-Competitive Practices & Trade Secret Theft

The Evolving Role of Physician Advisors: Bridging the Gap Between Clinicians and Administrators

The Evolving Physician Advisor: From UM to Value-Based Care & AI

UnitedHealth Group Names Stephen Hemsley CEO as Andrew Witty Steps Down

UnitedHealth CEO Andrew Witty Steps Down, Stephen Hemsley Returns as CEO

Omada Health Files for IPO

Omada Health Files for IPO

Blue Cross Blue Shield of Massachusetts Launches "CloseKnit" Virtual-First Primary Care Option

Blue Cross Blue Shield of Massachusetts Launches “CloseKnit” Virtual-First Primary Care Option

Osteoboost Launches First FDA-Cleared Prescription Wearable Nationwide to Combat Low Bone Density

Osteoboost Launches First FDA-Cleared Prescription Wearable Nationwide to Combat Low Bone Density

2019 MedTech Breakthrough Award Category Winners Announced

MedTech Breakthrough Announces 2025 MedTech Breakthrough Award Winners

Secondary Sidebar

Footer

Company

  • About Us
  • Advertise with Us
  • Reprints and Permissions
  • Submit An Op-Ed
  • Contact
  • Subscribe

Editorial Coverage

  • Opinion
  • Health IT
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Population Health Management
    • Revenue Cycle Management
  • Digital Health
    • Artificial Intelligence
    • Blockchain Tech
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • Value-Based Care
    • Accountable Care
    • Medicare Advantage

Connect

Subscribe to HIT Consultant Media

Latest insightful articles delivered straight to your inbox weekly

Copyright © 2025. HIT Consultant Media. All Rights Reserved. Privacy Policy |